Defensedyne

Website
DeepTech,HealthTech

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Guy Har-Chen, Uri Barak
Pre-Seed
Israel
DeepTech, HealthTech
2024
DefenseDyne is developing a B2B medical device platform with an initial focus on total joint replacement. The system combines a single-use implantable biosensor, an external reader, and a software/monitoring layer. We plan to sell through healthcare providers and orthopedic systems, with insurance companies ultimately serving as the primary payers. Our initial revenue model combines per-procedure revenue from the implantable sensor, revenue from the external reader, and recurring software and monitoring fees. The economic proposition is driven by prevention and early intervention: in the U.S. alone, approximately 800,000 total knee replacements are performed annually, and although prosthetic joint infection occurs in only ~2.3% of cases, treating these infections creates an annual burden approaching $2B. Detecting infection earlier has the potential to avoid costly revision procedures and substantially reduce payer costs. The same business model can then expand to other joint replacements and, as the underlying continuous molecular sensing platform matures, into additional clinical applications where real-time molecular monitoring inside the body can create clinical and economic value.

DefenseDyne is building a platform for continuous implantable molecular sensing. Starting with early detection of infections following joint replacement, we aim to overcome biofouling and enable a new class of devices that continuously monitor molecular changes inside the body.